AA98-treated M-WT mice showed fewer TAMs and more CD8+ T cells than monoclonal-antibody (mAb) IgG (mIgG)-treated M-WT mice, suggesting that AA98 treatment reshaped the tumor immune microenvironment (TIME). The gene discussed is CD8A; the disease is neoplasm.